Neogen (NEOG) Financials

$6.06 -0.13 (-2.10%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$5.98 -0.07 (-1.24%)

As of 05/23/2025 05:59 PM Eastern

Annual Income Statements for Neogen

This table shows Neogen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015	5/31/2014
Net Income / (Loss) Attributable to Common Shareholders	-9.42	-23	48	61	59	60	63	44	37	34	28
Consolidated Net Income / (Loss)	-9.42	-23	48	61	59	60	63	44	37	34	28
Net Income / (Loss) Continuing Operations	-9.42	-23	48	61	59	60	63	44	37	34	28
Total Pre-Tax Income	-14	-22	60	75	72	73	73	67	56	52	43
Total Operating Income	59	38	59	74	68	68	70	65	56	53	43
Total Gross Profit	464	406	243	215	196	192	186	169	153	140	123
Total Revenue	924	822	527	468	418	414	398	358	321	283	247
Operating Revenue	924	822	527	468	418	414	398	358	321	283	247
Total Cost of Revenue	460	416	284	253	222	222	212	189	168	143	125
Operating Cost of Revenue	460	416	284	253	222	222	212	189	168	143	125
Total Operating Expenses	405	368	184	141	129	124	116	104	97	87	79
Selling, General & Admin Expense	200	201	83	51	44	41	38	34	29	25	24
Marketing Expense	183	141	85	73	70	70	67	59	58	52	46
Research & Development Expense	22	26	17	16	15	13	11	10	9.89	9.58	8.33
Total Other Income / (Expense), net	-73	-60	1.59	1.10	4.78	4.87	3.27	1.73	-0.87	-1.04	-0.36
Interest Expense	73	56	0.07	0.08	-	-	-	-	-	-	-
Interest & Investment Income	6.36	3.17	1.34	1.69	5.99	4.83	2.19	1.01	0.54	0.38	0.35
Other Income / (Expense), net	-5.94	-6.76	0.32	-0.52	-1.21	0.03	1.08	0.72	-1.41	-1.42	-0.71
Income Tax Expense	-4.88	0.83	12	14	13	13	10	23	19	19	15
Basic Earnings per Share	($0.04)	($0.12)	$0.45	$0.57	$0.57	$0.58	$1.23	$0.87	$0.73	$0.91	$0.77
Weighted Average Basic Shares Outstanding	216.48M	188.88M	107.68M	106.50M	105.10M	103.78M	51.36M	50.54M	37.40M	36.95M	36.51M
Diluted Earnings per Share	($0.04)	($0.12)	$0.45	$0.57	$0.56	$0.57	$1.21	$0.86	$0.72	$0.90	$0.76
Weighted Average Diluted Shares Outstanding	216.48M	188.88M	108.02M	107.12M	105.72M	104.85M	52.15M	50.54M	37.40M	36.95M	36.51M
Weighted Average Basic & Diluted Shares Outstanding	216.69M	216.31M	107.84M	107.48M	52.96M	51.89M	51.36M	50.54M	37.40M	36.95M	36.51M

This table shows Neogen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	2/28/2025	11/30/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2024	5/31/2023	2/28/2023	11/30/2022	8/31/2022	5/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-11	-456	-5.42	-2.02	-3.49	-13	5.57	8.19	-42	5.21	15
Consolidated Net Income / (Loss)	-11	-456	-5.42	-2.02	-3.49	-13	5.57	8.19	-42	5.21	15
Net Income / (Loss) Continuing Operations	-11	-456	-5.42	-2.02	-3.49	-13	5.57	8.19	-42	5.21	15
Total Pre-Tax Income	-9.73	-477	-6.40	-5.82	-3.75	-16	7.65	-2.26	-34	6.66	19
Total Operating Income	5.42	-457	13	12	14	2.26	23	16	-7.66	6.06	18
Total Gross Profit	110	113	113	117	117	105	123	108	113	62	65
Total Revenue	221	231	237	229	230	217	242	218	230	132	140
Operating Revenue	221	231	237	229	230	217	242	218	230	132	140
Total Cost of Revenue	111	118	123	112	113	112	119	110	117	70	75
Operating Cost of Revenue	111	118	123	112	113	112	119	110	117	70	75
Total Operating Expenses	105	571	100	105	102	103	100	92	120	56	47
Selling, General & Admin Expense	56	58	51	52	52	52	50	46	77	28	22
Marketing Expense	45	47	44	48	45	46	43	39	36	23	21
Research & Development Expense	4.47	5.11	5.15	4.85	5.76	5.20	7.05	7.26	6.85	4.88	3.83
Impairment Charge	0.00	461	-	-	0.00	-	-	-	-	-	-
Total Other Income / (Expense), net	-15	-19	-19	-18	-18	-18	-16	-18	-26	0.60	0.88
Interest Expense	18	18	19	18	18	19	18	17	21	0.00	-
Interest & Investment Income	0.70	0.77	1.10	1.61	1.86	0.99	1.00	0.64	0.55	0.97	0.54
Other Income / (Expense), net	1.90	-1.72	-1.92	-1.17	-2.04	-0.24	1.18	-1.12	-6.44	-0.37	0.36
Income Tax Expense	1.23	-20	-0.98	-3.80	-0.26	-3.00	2.08	-10	7.75	1.45	3.95
Basic Earnings per Share	($0.05)	($2.10)	($0.02)	($0.01)	($0.02)	($0.06)	$0.03	$0.04	($0.19)	$0.05	$0.14
Weighted Average Basic Shares Outstanding	217.03M	216.81M	216.48M	216.60M	216.41M	216.70M	188.88M	216.22M	216.13M	107.84M	107.68M
Diluted Earnings per Share	($0.05)	($2.10)	($0.02)	($0.01)	($0.02)	($0.06)	$0.03	$0.04	($0.19)	$0.05	$0.14
Weighted Average Diluted Shares Outstanding	217.03M	216.81M	216.48M	216.60M	216.41M	216.70M	188.88M	216.40M	216.13M	107.86M	108.02M
Weighted Average Basic & Diluted Shares Outstanding	217.04M	216.94M	216.69M	216.61M	216.52M	216.70M	216.31M	216.22M	216.15M	107.84M	107.84M

This table details how cash moves in and out of Neogen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015	5/31/2014
Net Change in Cash & Equivalents	7.37	119	-31	9.33	25	-41	5.51	22	-11	25	-9.36
Net Cash From Operating Activities	35	41	68	81	86	64	69	60	35	44	22
Net Cash From Continuing Operating Activities	35	41	68	81	86	64	69	60	35	44	22
Net Income / (Loss) Continuing Operations	-9.42	-23	48	61	59	60	63	44	37	34	28
Consolidated Net Income / (Loss)	-9.42	-23	48	61	59	60	63	44	37	34	28
Depreciation Expense	117	88	24	21	18	18	17	15	12	11	9.18
Amortization Expense	7.95	4.82	0.44	0.00	-	-	-	-	-	-	-
Non-Cash Adjustments To Reconcile Net Income	20	14	0.02	6.44	6.47	5.54	4.91	1.34	2.52	1.98	-1.07
Changes in Operating Assets and Liabilities, net	-100	-43	-4.42	-7.27	1.54	-20	-16	0.27	-16	-2.41	-14
Net Cash From Investing Activities	-29	201	-97	-106	-89	-119	-83	-62	-61	-28	-51
Net Cash From Continuing Investing Activities	-29	201	-97	-106	-89	-119	-83	-62	-61	-28	-51
Purchase of Property, Plant & Equipment	-111	-66	-24	-27	-24	-15	-21	-15	-14	-9.62	-12
Acquisitions	0.00	12	-39	-51	-13	-6.39	-0.47	-34	-42	-6.55	-39
Purchase of Investments	0.00	-13	-416	-793	-458	-437	-361	-163	-152	-106	-92
Sale of Property, Plant & Equipment	0.11	0.83	0.00	0.00	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	82	267	382	765	407	339	300	149	147	94	91
Net Cash From Financing Activities	1.92	-118	6.81	34	29	14	23	25	15	11	20
Net Cash From Continuing Financing Activities	1.92	-118	6.81	34	29	14	23	25	15	11	20
Repayment of Debt	-0.54	-119	0.00	0.00	-	-	-	-	-	-	-
Issuance of Common Equity	2.46	1.20	7.93	35	29	17	23	21	-	-	-
Other Financing Activities, net	0.00	0.00	-1.12	-1.09	0.00	0.00	-0.42	3.92	15	11	20
Effect of Exchange Rate Changes	-0.50	-	-8.75	0.26	-1.92	0.02	-3.38	-0.90	-0.29	-0.98	0.66
Cash Interest Paid	73	43	0.07	0.08	-	-	-	-	-	-	-
Cash Income Taxes Paid	22	15	17	15	7.36	13	15	18	13	10	9.96

This table details how cash moves in and out of Neogen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/28/2025	5/31/2024	2/29/2024	11/30/2023	8/31/2024	5/31/2023	2/28/2023	11/30/2022	8/31/2022	5/31/2022	2/28/2022
Net Change in Cash & Equivalents	-13	9.17	-44	27	-50	93	-30	-13	68	1.59	-8.24
Net Cash From Operating Activities	19	27	-30	16	-18	91	-17	-19	-14	20	6.59
Net Cash From Continuing Operating Activities	19	27	-30	16	-18	91	-17	-19	-14	20	6.59
Net Income / (Loss) Continuing Operations	-11	-5.42	-2.02	-3.49	-13	5.57	8.19	-42	5.21	15	5.44
Consolidated Net Income / (Loss)	-11	-5.42	-2.02	-3.49	-13	5.57	8.19	-42	5.21	15	5.44
Depreciation Expense	29	29	30	29	30	28	27	27	5.73	5.86	6.32
Amortization Expense	0.86	5.37	0.86	0.86	0.86	2.96	0.86	1.00	0.00	0.44	-
Non-Cash Adjustments To Reconcile Net Income	6.18	9.64	3.69	4.27	3.80	3.48	6.61	2.18	1.87	-5.03	1.70
Changes in Operating Assets and Liabilities, net	-6.09	-12	-62	-15	-40	51	-60	-6.80	-27	4.16	-6.87
Net Cash From Investing Activities	-32	-18	-15	12	-34	6.88	20	93	82	-17	-15
Net Cash From Continuing Investing Activities	-32	-18	-15	12	-34	6.88	20	93	82	-17	-15
Purchase of Property, Plant & Equipment	-33	-24	-32	-24	-38	-26	-15	-12	-13	-13	-6.66
Sale of Property, Plant & Equipment	0.42	0.05	-0.01	0.03	4.45	0.14	0.08	0.61	0.00	-	-
Net Cash From Financing Activities	0.95	-0.08	1.25	-0.31	0.98	0.25	-40	-79	0.91	-1.03	1.22
Net Cash From Continuing Financing Activities	0.95	-0.08	1.25	-0.31	0.98	0.25	-40	-79	0.91	-1.03	1.22
Issuance of Common Equity	1.06	0.01	1.30	0.17	1.08	0.25	0.02	0.02	0.91	0.09	1.22
Other Financing Activities, net	-0.12	-	-	-	-	-	-	-	-	-	-
Effect of Exchange Rate Changes	-0.39	-	-	-	-	-	-	-	-	-0.67	-0.67

This table presents Neogen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015	5/31/2014
Total Assets	4,549	4,554	993	920	797	696	618	528	450	392	345
Total Current Assets	589	586	627	591	537	450	376	293	248	231	189
Cash & Equivalents	171	163	44	76	66	42	83	78	55	66	41
Short-Term Investments	0.33	82	337	305	277	226	128	66	53	48	36
Accounts Receivable	173	153	100	92	85	83	79	69	68	59	52
Inventories, net	189	134	122	101	95	86	76	73	64	52	51
Prepaid Expenses	56	53	24	18	14	13	9.89	7.61	8.41	4.23	7.46
Plant, Property, & Equipment, net	277	199	111	100	79	75	73	62	55	44	42
Total Noncurrent Assets	3,682	3,770	256	228	181	171	169	174	147	117	115
Goodwill	2,136	2,137	143	131	110	104	100	105	89	70	68
Intangible Assets	1,512	1,605	108	92	67	16	15	69	59	46	46
Other Noncurrent Operating Assets	35	27	5.34	4.50	4.18	52	55	-	-	-	-
Total Liabilities & Shareholders' Equity	4,549	4,554	993	920	797	696	618	528	450	392	345
Total Liabilities	1,405	1,420	106	80	72	58	58	57	46	41	39
Total Current Liabilities	154	145	78	54	48	38	39	36	29	25	25
Accounts Payable	83	77	35	24	26	19	21	16	16	14	13
Current Deferred Revenue	4.63	4.62	5.46	3.40	-	-	-	-	-	-	-
Current Deferred & Payable Income Tax Liabilities	10	6.95	2.13	1.85	1.46	0.60	0.17	0.94	0.00	1.28	0.00
Current Employee Benefit Liabilities	20	25	11	11	7.74	7.09	6.07	5.00	4.99	4.14	4.36
Other Current Liabilities	25	21	-	-	-	-	-	-	-	-	-
Other Current Nonoperating Liabilities	11	11	0.00	-	-	-	-	-	-	-	-
Total Noncurrent Liabilities	1,250	1,275	28	26	24	20	19	21	17	16	14
Long-Term Debt	888	885	0.00	-	-	-	-	-	-	2.05	1.88
Noncurrent Deferred & Payable Income Tax Liabilities	327	353	17	22	18	16	14	17	15	14	12
Other Noncurrent Operating Liabilities	35	36	11	4.30	5.39	3.97	5.04	3.60	2.42	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,144	3,134	887	840	725	638	560	472	404	351	306
Total Preferred & Common Equity	3,144	3,134	887	840	725	638	560	472	404	351	306
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,144	3,134	887	840	725	638	560	472	404	351	306
Common Stock	2,619	2,602	327	312	266	230	211	183	156	138	124
Retained Earnings	556	565	588	540	479	419	359	296	252	216	182
Accumulated Other Comprehensive Income / (Loss)	-30	-33	-28	-11	-20	-12	-9.75	-7.20	-3.95	-2.44	0.37

This table presents Neogen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	2/28/2025	11/30/2024	2/29/2024	11/30/2023	8/31/2024	2/28/2023	11/30/2022	8/31/2022	2/28/2022
Total Assets	4,036	4,054	4,582	4,602	4,503	4,509	4,563	977	981
Total Current Assets	552	570	602	624	541	555	643	608	610
Cash & Equivalents	128	140	161	206	120	67	100	107	43
Short-Term Investments	0.00	0.00	7.01	25	0.00	116	176	241	336
Accounts Receivable	160	164	174	150	168	146	143	93	93
Inventories, net	205	198	182	161	199	144	136	129	113
Prepaid Expenses	58	68	78	83	54	82	88	38	25
Plant, Property, & Equipment, net	328	311	272	244	301	165	148	121	105
Total Noncurrent Assets	3,157	3,173	3,708	3,734	3,662	3,789	3,772	246	267
Goodwill	1,672	1,673	2,136	2,138	2,137	2,135	2,122	140	150
Intangible Assets	1,439	1,463	1,540	1,565	1,490	1,634	1,642	15	112
Other Noncurrent Operating Assets	46	37	32	31	34	19	7.61	91	4.78
Total Liabilities & Shareholders' Equity	4,036	4,054	4,582	4,602	4,503	4,509	4,563	977	981
Total Liabilities	1,376	1,385	1,436	1,455	1,368	1,383	1,457	94	106
Total Current Liabilities	141	151	158	177	123	107	153	67	66
Accounts Payable	72	80	90	112	61	60	79	27	24
Current Deferred Revenue	5.77	5.65	5.49	4.68	5.64	6.77	5.08	5.46	-
Current Deferred & Payable Income Tax Liabilities	13	11	12	10	11	1.65	9.05	3.92	0.00
Current Employee Benefit Liabilities	18	16	20	16	16	17	15	8.30	9.66
Other Current Liabilities	28	25	2.52	-	25	-	-	-	-
Other Current Nonoperating Liabilities	3.44	11	3.44	11	3.55	3.44	14	-	-
Total Noncurrent Liabilities	1,235	1,234	1,278	1,278	1,245	1,276	1,304	27	40
Long-Term Debt	891	890	888	887	889	885	924	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	301	302	354	355	318	363	364	16	21
Other Noncurrent Operating Liabilities	43	42	37	36	39	29	16	11	19
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,660	2,669	3,146	3,148	3,135	3,126	3,106	884	876
Total Preferred & Common Equity	2,660	2,669	3,146	3,148	3,135	3,126	3,106	884	876
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,660	2,669	3,146	3,148	3,135	3,126	3,106	884	876
Common Stock	2,632	2,627	2,615	2,610	2,624	2,599	2,595	330	325
Retained Earnings	76	87	561	563	543	559	551	593	573
Accumulated Other Comprehensive Income / (Loss)	-48	-45	-29	-25	-31	-33	-40	-39	-22

This table displays calculated financial ratios and metrics derived from Neogen's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015	5/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.37%	56.02%	12.53%	12.03%	0.96%	4.09%	11.07%	11.52%	13.50%	14.42%	19.22%
EBITDA Growth	43.12%	49.20%	-12.27%	11.79%	-1.21%	-2.92%	9.93%	19.66%	7.71%	20.21%	7.95%
EBIT Growth	71.45%	-47.82%	-19.98%	11.07%	-2.66%	-4.42%	8.55%	19.45%	6.34%	21.12%	5.05%
NOPAT Growth	56.37%	-44.16%	-21.60%	8.01%	-1.11%	-7.01%	41.01%	15.41%	8.36%	21.16%	5.65%
Net Income Growth	58.81%	-147.34%	-20.65%	2.37%	-1.16%	-4.81%	43.76%	20.35%	8.82%	19.78%	3.66%
EPS Growth	66.67%	-126.67%	-21.05%	2.37%	-1.16%	-4.81%	40.70%	20.35%	8.82%	18.42%	1.33%
Operating Cash Flow Growth	-14.05%	-39.70%	-16.09%	-5.58%	34.52%	-7.65%	14.69%	70.60%	-19.32%	102.10%	-18.42%
Free Cash Flow Firm Growth	98.58%	-349,034,399.41%	99.99%	-140.19%	25.45%	-9.87%	253.52%	154.29%	-175.34%	195.37%	-699.58%
Invested Capital Growth	2.31%	647.59%	10.24%	20.39%	3.04%	5.97%	6.47%	10.72%	24.08%	3.09%	32.37%
Revenue Q/Q Growth	-0.54%	14.11%	2.46%	4.08%	-0.16%	0.40%	3.27%	1.54%	3.70%	4.18%	4.77%
EBITDA Q/Q Growth	-5.66%	33.81%	-1.60%	1.74%	2.26%	-0.98%	0.89%	5.69%	2.15%	5.86%	3.11%
EBIT Q/Q Growth	-20.36%	25.35%	-2.84%	0.73%	2.49%	-1.55%	0.57%	5.94%	1.58%	6.58%	2.80%
NOPAT Q/Q Growth	-15.04%	16.81%	-3.29%	0.82%	0.36%	-3.86%	8.61%	6.08%	1.16%	6.81%	1.43%
Net Income Q/Q Growth	-701.60%	-69.62%	-1.63%	-0.96%	0.90%	-2.79%	8.69%	6.47%	1.07%	5.93%	2.10%
EPS Q/Q Growth	-500.00%	-100.00%	-2.17%	-0.96%	0.90%	-2.79%	7.08%	6.47%	1.07%	4.65%	1.33%
Operating Cash Flow Q/Q Growth	-64.55%	238.85%	-2.27%	-4.32%	5.86%	-2.56%	12.11%	14.79%	-16.78%	29.34%	-9.09%
Free Cash Flow Firm Q/Q Growth	-563.02%	1.76%	-100.02%	-63.45%	-0.79%	0.94%	8.37%	144.13%	-339.24%	35.71%	-20.73%
Invested Capital Q/Q Growth	0.10%	-1.18%	1.85%	1.09%	-0.64%	-0.80%	-0.12%	-0.66%	11.91%	0.92%	3.17%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.19%	49.36%	46.10%	45.91%	46.94%	46.34%	46.81%	47.15%	47.64%	49.35%	49.55%
EBITDA Margin	19.19%	15.07%	15.76%	20.21%	20.26%	20.70%	22.20%	22.43%	20.90%	22.03%	20.96%
Operating Margin	6.35%	4.56%	11.12%	15.83%	16.15%	16.44%	17.64%	18.13%	17.55%	18.76%	17.54%
EBIT Margin	5.71%	3.74%	11.18%	15.72%	15.86%	16.45%	17.91%	18.33%	17.11%	18.26%	17.25%
Profit (Net Income) Margin	-1.02%	-2.78%	9.16%	13.00%	14.22%	14.53%	15.89%	12.27%	11.37%	11.86%	11.33%
Tax Burden Percent	65.86%	103.76%	80.23%	80.89%	82.26%	82.48%	86.05%	65.95%	65.82%	64.48%	65.14%
Interest Burden Percent	-27.13%	-71.67%	102.15%	102.19%	109.04%	107.09%	103.07%	101.54%	100.98%	100.73%	100.81%
Effective Tax Rate	0.00%	0.00%	19.77%	19.11%	17.74%	17.52%	13.95%	34.05%	34.18%	35.53%	34.86%
Return on Invested Capital (ROIC)	1.07%	1.22%	9.74%	14.27%	14.78%	15.61%	17.83%	13.72%	13.87%	14.56%	13.90%
ROIC Less NNEP Spread (ROIC-NNEP)	-6.25%	-35.17%	9.41%	14.03%	13.49%	13.93%	16.24%	12.81%	14.39%	15.28%	14.20%
Return on Net Nonoperating Assets (RNNOA)	-1.37%	-2.36%	-4.15%	-6.49%	-6.05%	-5.56%	-5.58%	-3.68%	-4.19%	-4.34%	-3.97%
Return on Equity (ROE)	-0.30%	-1.14%	5.59%	7.78%	8.73%	10.05%	12.25%	10.04%	9.68%	10.22%	9.93%
Cash Return on Invested Capital (CROIC)	-1.21%	-151.58%	0.00%	-4.23%	11.78%	9.81%	11.56%	3.55%	-7.62%	11.51%	-13.96%
Operating Return on Assets (OROA)	1.16%	1.11%	6.16%	8.58%	8.88%	10.37%	12.43%	13.42%	13.06%	14.02%	13.43%
Return on Assets (ROA)	-0.21%	-0.82%	5.05%	7.09%	7.97%	9.16%	11.03%	8.99%	8.68%	9.11%	8.82%
Return on Common Equity (ROCE)	-0.30%	-1.14%	5.59%	7.78%	8.73%	10.05%	12.25%	10.04%	9.68%	10.22%	9.93%
Return on Equity Simple (ROE_SIMPLE)	-0.30%	-0.73%	5.44%	7.24%	8.20%	9.43%	11.28%	9.32%	9.04%	9.57%	9.15%
Net Operating Profit after Tax (NOPAT)	41	26	47	60	56	56	60	43	37	34	28
NOPAT Margin	4.44%	3.19%	8.92%	12.81%	13.28%	13.56%	15.18%	11.96%	11.55%	12.10%	11.42%
Net Nonoperating Expense Percent (NNEP)	7.32%	36.40%	0.33%	0.25%	1.29%	1.68%	1.59%	0.91%	-0.52%	-0.72%	-0.30%
Cost of Revenue to Revenue	49.81%	50.64%	53.90%	54.09%	53.06%	53.66%	53.19%	52.85%	52.36%	50.65%	50.45%
SG&A Expenses to Revenue	21.63%	24.46%	15.70%	10.93%	10.60%	9.85%	9.62%	9.55%	9.09%	8.91%	9.88%
R&D to Revenue	2.43%	3.17%	3.23%	3.47%	3.53%	3.09%	2.73%	2.90%	3.08%	3.38%	3.37%
Operating Expenses to Revenue	43.85%	44.80%	34.98%	30.07%	30.79%	29.90%	29.17%	29.02%	30.09%	30.58%	32.02%
Earnings before Interest and Taxes (EBIT)	53	31	59	74	66	68	71	66	55	52	43
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	177	124	83	95	85	86	88	80	67	62	52
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.91	1.21	3.22	5.88	5.20	4.60	6.97	5.12	4.58	4.93	4.52
Price to Tangible Book Value (P/TBV)	0.00	0.00	4.48	8.01	6.87	5.66	8.76	8.10	7.20	7.38	7.23
Price to Revenue (P/Rev)	3.08	4.60	5.41	10.54	9.01	7.09	9.81	6.73	5.77	6.12	5.60
Price to Earnings (P/E)	0.00	0.00	59.06	81.13	63.36	48.81	61.85	55.09	50.67	51.64	49.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	1.69%	1.23%	1.58%	2.05%	1.62%	1.82%	1.97%	1.94%	2.03%
Enterprise Value to Invested Capital (EV/IC)	0.92	1.17	4.88	9.93	8.98	7.21	10.58	6.92	5.89	6.78	5.66
Enterprise Value to Revenue (EV/Rev)	3.86	5.38	4.69	9.73	8.19	6.45	9.28	6.33	5.43	5.72	5.30
Enterprise Value to EBITDA (EV/EBITDA)	20.10	35.67	29.76	48.14	40.43	31.13	41.83	28.24	25.98	25.97	25.28
Enterprise Value to EBIT (EV/EBIT)	67.63	143.78	41.94	61.89	51.64	39.18	51.84	34.56	31.74	31.32	30.71
Enterprise Value to NOPAT (EV/NOPAT)	86.84	168.37	52.56	75.98	61.66	47.53	61.17	52.97	47.01	47.28	46.38
Enterprise Value to Operating Cash Flow (EV/OCF)	101.12	107.77	36.33	56.22	39.88	41.81	53.44	37.65	49.38	36.98	60.50
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	77.35	75.64	94.35	204.86	0.00	59.79	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.28	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01
Long-Term Debt to Equity	0.28	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01
Financial Leverage	0.22	0.07	-0.44	-0.46	-0.45	-0.40	-0.34	-0.29	-0.29	-0.28	-0.28
Leverage Ratio	1.45	1.38	1.11	1.10	1.10	1.10	1.11	1.12	1.12	1.12	1.13
Compound Leverage Factor	-0.39	-0.99	1.13	1.12	1.19	1.17	1.15	1.13	1.13	1.13	1.14
Debt to Total Capital	22.03%	22.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.58%	0.61%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	22.03%	22.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.58%	0.61%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	-0.01%	0.00%	-0.02%
Common Equity to Total Capital	77.97%	77.97%	100.00%	100.00%	100.00%	100.00%	100.00%	99.97%	100.01%	99.42%	99.41%
Debt to EBITDA	5.01	7.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.04
Net Debt to EBITDA	4.04	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.80	-1.44
Long-Term Debt to EBITDA	5.01	7.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.04
Debt to NOPAT	21.63	33.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.07
Net Debt to NOPAT	17.47	24.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-3.27	-2.64
Long-Term Debt to NOPAT	21.63	33.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.07
Altman Z-Score	1.74	2.09	18.44	39.43	33.78	32.94	43.01	28.01	26.77	27.76	23.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	-0.01%	-0.01%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.82	4.03	8.05	11.03	11.08	11.75	9.71	8.14	8.68	9.08	7.56
Quick Ratio	2.23	2.74	6.18	8.82	8.83	9.15	7.49	5.89	6.14	6.81	5.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-46	-3,253	-0.00	-18	44	35	39	11	-20	27	-28
Operating Cash Flow to CapEx	31.68%	63.19%	278.51%	303.57%	357.05%	435.45%	330.04%	413.46%	248.43%	455.27%	187.72%
Free Cash Flow to Firm to Interest Expense	-0.63	-58.12	-0.01	-228.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.48	0.73	944.97	1,039.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-1.04	-0.43	605.68	697.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.20	0.30	0.55	0.55	0.56	0.63	0.69	0.73	0.76	0.77	0.78
Accounts Receivable Turnover	5.67	6.50	5.51	5.31	5.00	5.12	5.39	5.26	5.07	5.10	5.46
Inventory Turnover	2.85	3.25	2.55	2.59	2.45	2.74	2.84	2.75	2.90	2.79	2.79
Fixed Asset Turnover	3.88	5.32	5.00	5.23	5.45	5.60	5.90	6.15	6.48	6.55	6.49
Accounts Payable Turnover	5.76	7.49	9.71	10.23	9.93	11.17	11.44	11.82	11.41	10.59	11.04
Days Sales Outstanding (DSO)	64.42	56.12	66.30	68.76	73.00	71.23	67.72	69.39	72.06	71.63	66.86
Days Inventory Outstanding (DIO)	128.09	112.23	143.24	140.98	148.91	133.01	128.60	132.54	125.82	130.81	130.86
Days Payable Outstanding (DPO)	63.33	48.76	37.58	35.69	36.78	32.69	31.90	30.88	32.00	34.48	33.06
Cash Conversion Cycle (CCC)	129.19	119.59	171.95	174.06	185.13	171.56	164.43	171.05	165.89	167.97	164.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,873	3,785	506	459	382	370	349	328	296	239	232
Invested Capital Turnover	0.24	0.38	1.09	1.11	1.11	1.15	1.17	1.15	1.20	1.20	1.22
Increase / (Decrease) in Invested Capital	87	3,279	47	78	11	21	21	32	58	7.17	57
Enterprise Value (EV)	3,566	4,422	2,472	4,559	3,425	2,669	3,695	2,269	1,745	1,619	1,311
Market Capitalization	2,848	3,782	2,853	4,940	3,768	2,937	3,905	2,413	1,853	1,731	1,386
Book Value per Share	$14.52	$14.50	$8.23	$15.70	$13.71	$12.24	$10.86	$12.37	$10.77	$9.48	$8.36
Tangible Book Value per Share	($2.32)	($2.81)	$5.91	$11.52	$10.36	$9.95	$8.64	$7.82	$6.85	$6.33	$5.23
Total Capital	4,033	4,020	887	840	725	638	560	472	404	353	308
Total Debt	888	885	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.05	1.88
Total Long-Term Debt	888	885	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.05	1.88
Net Debt	717	640	-381	-381	-344	-268	-211	-144	-108	-112	-75
Capital Expenditures (CapEx)	111	65	24	27	24	15	21	15	14	9.62	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	264	195	168	157	145	144	126	113	112	92	87
Debt-free Net Working Capital (DFNWC)	435	440	549	538	489	411	337	257	220	206	164
Net Working Capital (NWC)	435	440	549	538	489	411	337	257	220	206	164
Net Nonoperating Expense (NNE)	50	49	-1.27	-0.89	-3.93	-4.01	-2.81	-1.14	0.57	0.67	0.23
Net Nonoperating Obligations (NNO)	728	651	-381	-381	-344	-268	-211	-144	-108	-112	-75
Total Depreciation and Amortization (D&A)	125	93	24	21	18	18	17	15	12	11	9.18
Debt-free, Cash-free Net Working Capital to Revenue	28.56%	23.70%	31.85%	33.46%	34.73%	34.71%	31.74%	31.63%	34.81%	32.35%	35.28%
Debt-free Net Working Capital to Revenue	47.06%	53.55%	104.13%	114.81%	116.92%	99.30%	84.71%	71.72%	68.36%	72.68%	66.20%
Net Working Capital to Revenue	47.06%	53.55%	104.13%	114.81%	116.92%	99.30%	84.71%	71.72%	68.36%	72.68%	66.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.04)	($0.12)	$0.45	$0.57	$0.57	$0.58	$0.62	$0.43	$0.37	$0.34	$0.29
Adjusted Weighted Average Basic Shares Outstanding	216.48M	188.88M	107.68M	106.50M	105.10M	104.56M	103.51M	101.90M	100.20M	99.02M	97.96M
Adjusted Diluted Earnings per Share	($0.04)	($0.12)	$0.45	$0.57	$0.57	$0.58	$0.61	$0.43	$0.36	$0.34	$0.29
Adjusted Weighted Average Diluted Shares Outstanding	216.48M	188.88M	108.02M	107.12M	105.72M	104.56M	103.51M	101.90M	100.20M	99.02M	97.96M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	216.69M	216.31M	107.84M	107.48M	105.93M	104.56M	103.51M	101.90M	100.20M	99.02M	97.96M
Normalized Net Operating Profit after Tax (NOPAT)	41	26	47	60	56	56	60	43	37	34	28
Normalized NOPAT Margin	4.44%	3.19%	8.92%	12.81%	13.28%	13.56%	15.18%	11.96%	11.55%	12.10%	11.42%
Pre Tax Income Margin	-1.55%	-2.68%	11.42%	16.07%	17.29%	17.62%	18.46%	18.61%	17.28%	18.40%	17.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.72	0.55	818.61	944.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.56	0.47	653.22	769.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-0.80	-0.61	479.32	601.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-0.96	-0.69	313.93	426.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	5.21%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Neogen's official financial filings.

Metric	Q3 2025	Q2 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	2/28/2025	11/30/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022	5/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.42%	0.71%	-2.07%	4.84%	-0.18%	73.02%	72.61%	70.19%	76.25%	3.15%	9.94%
EBITDA Growth	-9.23%	-1,174.14%	-19.00%	-3.57%	213.47%	319.68%	126.88%	239.04%	-26.41%	-58.03%	-5.20%
EBIT Growth	-32.62%	-3,796.71%	-54.78%	-25.47%	188.11%	222.13%	33.83%	130.05%	-210.98%	-73.56%	-8.56%
NOPAT Growth	-54.96%	-3,262.70%	-46.50%	-23.34%	288.94%	264.70%	19.64%	110.12%	-151.32%	-72.25%	-10.00%
Net Income Growth	-441.89%	-12,985.23%	-197.18%	-124.69%	91.67%	-71.15%	-62.75%	50.47%	-486.41%	-69.50%	-5.08%
EPS Growth	-400.00%	-10,400.00%	-166.67%	-125.00%	89.47%	-80.00%	-78.57%	-20.00%	-290.00%	-68.75%	-6.67%
Operating Cash Flow Growth	164.10%	0.00%	-70.60%	-76.96%	183.92%	262.69%	346.13%	-358.97%	-204.93%	-160.93%	-7.19%
Free Cash Flow Firm Growth	1,590.29%	263.78%	97.60%	99.10%	98.79%	-4,392.45%	-9,853.24%	-8,749.35%	-4,065.32%	-40.08%	47.09%
Invested Capital Growth	-11.43%	-10.09%	2.31%	1.00%	1.32%	631.82%	647.59%	670.56%	691.19%	17.48%	10.24%
Revenue Q/Q Growth	-4.44%	0.00%	3.49%	-0.36%	0.28%	-5.30%	10.79%	-5.12%	73.81%	-5.53%	9.24%
EBITDA Q/Q Growth	108.18%	0.00%	9.66%	-3.25%	-10.79%	-14.42%	30.56%	214.50%	19.43%	-53.74%	95.10%
EBIT Q/Q Growth	101.59%	0.00%	2.53%	-12.65%	-32.23%	-25.50%	68.97%	203.27%	-347.79%	-69.05%	190.46%
NOPAT Q/Q Growth	101.18%	0.00%	8.46%	-16.88%	-41.45%	1.36%	55.41%	304.86%	-213.02%	-66.75%	172.94%
Net Income Q/Q Growth	97.60%	0.00%	-167.80%	42.01%	-332.00%	-73.03%	-31.97%	119.57%	-903.24%	-65.18%	174.83%
EPS Q/Q Growth	97.62%	0.00%	-100.00%	50.00%	-300.00%	-66.67%	-25.00%	121.05%	-480.00%	-64.29%	180.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	188.55%	-292.22%	-31.71%	-74.71%	632.93%	8.85%	-32.40%	-169.36%	209.36%
Free Cash Flow Firm Q/Q Growth	584.37%	0.00%	-161.41%	24.79%	98.81%	-2.89%	1.82%	-0.77%	-4,313.23%	-127.96%	12.71%
Invested Capital Q/Q Growth	-0.17%	0.00%	0.10%	1.34%	-2.29%	3.23%	-1.18%	1.66%	605.68%	5.45%	1.85%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.90%	49.01%	47.92%	51.08%	50.85%	50.99%	50.94%	49.47%	48.92%	47.05%	46.40%
EBITDA Margin	16.99%	-198.57%	19.16%	18.08%	18.62%	20.93%	23.16%	19.65%	5.93%	8.63%	17.62%
Operating Margin	2.45%	-197.82%	5.51%	5.25%	6.30%	8.36%	9.69%	7.19%	-3.33%	4.58%	12.87%
EBIT Margin	3.31%	-198.57%	4.70%	4.74%	5.41%	8.00%	10.17%	6.67%	-6.13%	4.30%	13.12%
Profit (Net Income) Margin	-4.96%	-197.30%	-2.29%	-0.88%	-1.52%	0.66%	2.30%	3.75%	-18.19%	3.94%	10.68%
Tax Burden Percent	112.65%	95.74%	84.62%	34.73%	93.06%	90.38%	72.84%	-362.39%	122.73%	78.23%	79.11%
Interest Burden Percent	-133.05%	103.78%	-57.52%	-53.65%	-30.16%	9.07%	31.10%	-15.52%	241.80%	117.03%	102.86%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	9.62%	27.16%	0.00%	0.00%	21.78%	20.89%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.93%	0.89%	1.05%	3.08%	2.70%	1.68%	-0.69%	3.85%	11.12%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-1.18%	-0.57%	-0.99%	-4.39%	-5.81%	-0.03%	-27.48%	3.73%	10.93%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-0.26%	-0.13%	-0.21%	-0.46%	-0.39%	0.00%	-1.88%	-1.61%	-4.82%
Return on Equity (ROE)	0.00%	0.00%	0.67%	0.76%	0.84%	2.62%	2.31%	1.67%	-2.58%	2.24%	6.29%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-1.21%	0.26%	-0.29%	-150.85%	-151.58%	-153.01%	-154.36%	-9.06%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	0.95%	0.97%	1.07%	2.65%	3.02%	1.75%	-1.40%	2.39%	7.23%
Return on Assets (ROA)	0.00%	0.00%	-0.46%	-0.18%	-0.30%	0.22%	0.68%	0.99%	-4.15%	2.19%	5.88%
Return on Common Equity (ROCE)	0.00%	0.00%	0.67%	0.76%	0.84%	2.62%	2.31%	1.67%	-2.58%	2.24%	6.29%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.05%	-0.07%	-1.30%	0.00%	-0.43%	-0.52%	4.12%	0.00%
Net Operating Profit after Tax (NOPAT)	3.79	-320	9.13	8.42	10	17	17	11	-5.36	4.74	14
NOPAT Margin	1.72%	-138.48%	3.85%	3.68%	4.41%	7.55%	7.06%	5.03%	-2.33%	3.58%	10.18%
Net Nonoperating Expense Percent (NNEP)	1.98%	18.98%	2.11%	1.46%	2.04%	7.48%	8.51%	1.71%	26.79%	0.12%	0.18%
Return On Investment Capital (ROIC_SIMPLE)	0.11%	-8.99%	-	-	0.25%	0.43%	-	-	-	-	-
Cost of Revenue to Revenue	50.10%	50.99%	52.08%	48.92%	49.15%	49.01%	49.06%	50.53%	51.08%	52.95%	53.60%
SG&A Expenses to Revenue	25.24%	24.98%	21.52%	22.76%	22.52%	19.70%	20.60%	21.27%	33.47%	21.11%	15.53%
R&D to Revenue	2.02%	2.21%	2.17%	2.12%	2.51%	2.94%	2.92%	3.33%	2.98%	3.69%	2.73%
Operating Expenses to Revenue	47.45%	246.83%	42.42%	45.83%	44.55%	42.63%	41.25%	42.28%	52.25%	42.47%	33.53%
Earnings before Interest and Taxes (EBIT)	7.31	-459	11	11	12	18	25	15	-14	5.69	18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	38	-459	45	41	43	48	56	43	14	11	25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.82	1.15	0.91	1.18	1.17	1.60	1.21	1.22	0.57	2.55	3.22
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.09	4.48
Price to Revenue (P/Rev)	0.00	0.00	3.08	4.01	4.05	5.51	4.60	5.31	2.83	4.24	5.41
Price to Earnings (P/E)	0.00	0.00	0.00	2,376.75	0.00	0.00	0.00	0.00	0.00	61.84	59.06
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.04%	0.00%	0.00%	0.00%	0.00%	0.00%	1.62%	1.69%
Enterprise Value to Invested Capital (EV/IC)	0.86	1.11	0.92	1.15	1.13	1.48	1.17	1.18	0.65	3.57	4.88
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	3.86	4.78	4.78	6.36	5.38	6.28	3.86	3.59	4.69
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	20.10	23.62	24.99	39.74	35.67	48.85	39.92	28.51	29.76
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	67.63	67.08	80.79	213.09	143.78	184.45	149.26	44.21	41.94
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	86.84	91.89	110.79	244.51	168.37	201.28	152.40	54.98	52.56
Enterprise Value to Operating Cash Flow (EV/OCF)	43.00	202.59	101.12	44.64	38.45	73.80	107.77	0.00	0.00	62.10	36.33
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	444.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.33	0.33	0.28	0.28	0.28	0.28	0.28	0.28	0.30	0.00	0.00
Long-Term Debt to Equity	0.33	0.33	0.28	0.28	0.28	0.28	0.28	0.28	0.30	0.00	0.00
Financial Leverage	0.26	0.25	0.22	0.23	0.21	0.11	0.07	0.08	0.07	-0.43	-0.44
Leverage Ratio	1.48	1.49	1.45	1.45	1.47	1.36	1.38	1.37	1.39	1.10	1.11
Compound Leverage Factor	-1.97	1.54	-0.83	-0.78	-0.44	0.12	0.43	-0.21	3.37	1.28	1.14
Debt to Total Capital	25.08%	25.06%	22.03%	22.01%	22.03%	22.09%	22.03%	22.06%	22.93%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.07%	0.00%	0.00%	0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	25.08%	24.99%	22.03%	22.01%	21.97%	22.09%	22.03%	22.06%	22.93%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	74.92%	74.94%	77.97%	77.99%	77.97%	77.91%	77.97%	77.94%	77.07%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	5.01	4.72	5.13	6.12	7.14	9.55	15.16	0.00	0.00
Net Debt to EBITDA	0.00	0.00	4.04	3.82	3.81	5.29	5.16	7.57	10.63	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	5.01	4.72	5.12	6.12	7.14	9.55	15.16	0.00	0.00
Debt to NOPAT	0.00	0.00	21.63	18.37	22.76	37.68	33.72	39.35	57.87	0.00	0.00
Net Debt to NOPAT	0.00	0.00	17.47	14.88	16.87	32.57	24.37	31.20	40.56	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	21.63	18.37	22.69	37.68	33.72	39.35	57.87	0.00	0.00
Altman Z-Score	0.00	0.00	1.71	2.05	2.01	2.69	2.09	2.12	1.16	16.52	18.30
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.91	3.77	3.82	3.82	3.54	4.41	4.03	5.18	4.22	9.07	8.05
Quick Ratio	2.04	2.01	2.23	2.17	2.16	2.35	2.74	3.08	2.75	6.58	6.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	446	65	-78	-30	-40	-3,356	-3,262	-3,322	-3,297	-75	-33
Operating Cash Flow to CapEx	59.68%	0.00%	110.49%	-94.01%	64.44%	75.22%	358.70%	-113.23%	-162.83%	-108.83%	162.63%
Free Cash Flow to Firm to Interest Expense	25.14	3.59	-4.20	-1.64	-2.21	-181.85	-181.68	-190.29	-160.48	-37,353.50	0.00
Operating Cash Flow to Interest Expense	1.09	0.00	1.44	-1.65	0.87	1.25	5.07	-0.98	-0.91	-7,071.50	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.74	0.00	0.14	-3.41	-0.48	-0.41	3.65	-1.84	-1.47	-13,569.50	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.20	0.20	0.20	0.33	0.30	0.26	0.23	0.56	0.55
Accounts Receivable Turnover	0.00	0.00	5.67	5.81	6.18	6.96	6.50	6.02	5.36	5.89	5.51
Inventory Turnover	0.00	0.00	2.85	2.79	3.06	2.80	3.25	2.90	2.74	2.47	2.55
Fixed Asset Turnover	0.00	0.00	3.88	4.25	4.62	4.30	5.32	5.35	5.07	4.82	5.00
Accounts Payable Turnover	0.00	0.00	5.76	6.07	4.74	10.36	7.49	8.88	5.88	11.57	9.71
Days Sales Outstanding (DSO)	0.00	0.00	64.42	62.84	59.02	52.46	56.12	60.61	68.06	61.98	66.30
Days Inventory Outstanding (DIO)	0.00	0.00	128.09	130.68	119.28	130.42	112.23	125.88	133.06	147.54	143.24
Days Payable Outstanding (DPO)	0.00	0.00	63.33	60.18	76.99	35.22	48.76	41.12	62.10	31.54	37.58
Cash Conversion Cycle (CCC)	0.00	0.00	129.19	133.34	101.31	147.67	119.59	145.37	139.02	177.97	171.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,427	3,432	3,873	3,869	3,818	3,907	3,785	3,830	3,768	534	506
Invested Capital Turnover	0.00	0.00	0.24	0.24	0.24	0.41	0.38	0.33	0.30	1.07	1.09
Increase / (Decrease) in Invested Capital	-442	-385	87	38	50	3,373	3,279	3,333	3,292	79	47
Enterprise Value (EV)	2,943	3,825	3,566	4,441	4,330	5,770	4,422	4,525	2,433	1,906	2,472
Market Capitalization	2,180	3,073	2,848	3,722	3,671	5,001	3,782	3,824	1,786	2,253	2,853
Book Value per Share	$12.26	$12.32	$14.52	$14.53	$14.55	$14.49	$14.50	$14.46	$28.81	$8.20	$8.23
Tangible Book Value per Share	($2.08)	($2.15)	($2.32)	($2.45)	($2.57)	($2.27)	($2.81)	($2.98)	($6.10)	$6.76	$5.91
Total Capital	3,551	3,562	4,033	4,034	4,037	4,024	4,020	4,010	4,030	884	887
Total Debt	891	892	888	888	889	889	885	885	924	0.00	0.00
Total Long-Term Debt	891	890	888	888	887	889	885	885	924	0.00	0.00
Net Debt	763	752	717	719	659	769	640	701	648	-348	-381
Capital Expenditures (CapEx)	32	0.00	24	32	24	31	25	15	12	13	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	283	282	264	276	220	297	195	265	214	193	168
Debt-free Net Working Capital (DFNWC)	411	422	435	445	450	418	440	448	491	541	549
Net Working Capital (NWC)	411	419	435	445	448	418	440	448	491	541	549
Net Nonoperating Expense (NNE)	15	136	15	10	14	16	11	2.79	36	-0.47	-0.70
Net Nonoperating Obligations (NNO)	766	763	728	723	670	772	651	705	662	-350	-381
Total Depreciation and Amortization (D&A)	30	0.00	34	31	30	30	31	28	28	5.73	6.30
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	28.56%	29.72%	24.27%	32.80%	23.70%	36.77%	34.00%	36.37%	31.85%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	47.06%	47.85%	49.67%	46.08%	53.55%	62.19%	77.81%	101.83%	104.13%
Net Working Capital to Revenue	0.00%	0.00%	47.06%	47.85%	49.39%	46.08%	53.55%	62.19%	77.81%	101.83%	104.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.05)	($2.10)	($0.02)	($0.01)	($0.02)	$0.01	$0.03	$0.04	($0.19)	$0.05	$0.14
Adjusted Weighted Average Basic Shares Outstanding	217.03M	216.81M	216.48M	216.60M	216.41M	216.31M	188.88M	216.22M	216.13M	107.84M	107.68M
Adjusted Diluted Earnings per Share	($0.05)	($2.10)	($0.02)	($0.01)	($0.02)	$0.01	$0.03	$0.04	($0.19)	$0.05	$0.14
Adjusted Weighted Average Diluted Shares Outstanding	217.03M	216.81M	216.48M	216.60M	216.41M	216.85M	188.88M	216.40M	216.13M	107.86M	108.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.03	$0.00	$0.00	$0.00	$0.14
Adjusted Weighted Average Basic & Diluted Shares Outstanding	217.04M	216.94M	216.69M	216.61M	216.52M	216.70M	216.31M	216.22M	216.15M	107.84M	107.84M
Normalized Net Operating Profit after Tax (NOPAT)	3.79	2.73	9.13	8.42	10	17	17	11	-5.36	4.74	14
Normalized NOPAT Margin	1.72%	1.18%	3.85%	3.68%	4.41%	7.55%	7.06%	5.03%	-2.33%	3.58%	10.18%
Pre Tax Income Margin	-4.40%	-206.08%	-2.70%	-2.54%	-1.63%	0.73%	3.16%	-1.04%	-14.82%	5.03%	13.50%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.41	-25.31	0.60	0.59	0.69	0.99	1.37	0.83	-0.69	2,845.00	0.00
NOPAT to Interest Expense	0.21	-17.65	0.49	0.46	0.56	0.94	0.95	0.63	-0.26	2,371.00	0.00
EBIT Less CapEx to Interest Expense	-1.42	0.00	-0.70	-1.16	-0.66	-0.66	-0.04	-0.03	-1.25	-3,653.00	0.00
NOPAT Less CapEx to Interest Expense	-1.62	0.00	-0.81	-1.30	-0.79	-0.72	-0.46	-0.23	-0.82	-4,127.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Neogen's Financials

When does Neogen's financial year end?

According to the most recent income statement we have on file, Neogen's fiscal year ends in May. Their fiscal year 2024 ended on May 31, 2024.

How has Neogen's net income changed over the last 10 years?

Neogen's net income appears to be on a downward trend, with a most recent value of -$9.42 million in 2024, falling from $28.03 million in 2014. The previous period was -$22.87 million in 2023. See where experts think Neogen is headed by visiting Neogen's forecast page.

What is Neogen's operating income?

Neogen's total operating income in 2024 was $58.66 million, based on the following breakdown:

Total Gross Profit: $463.90 million
Total Operating Expenses: $405.24 million

How has Neogen revenue changed over the last 10 years?

Over the last 10 years, Neogen's total revenue changed from $247.41 million in 2014 to $924.22 million in 2024, a change of 273.6%.

How much debt does Neogen have?

Neogen's total liabilities were at $1.40 billion at the end of 2024, a 1.1% decrease from 2023, and a 3,501.7% increase since 2014.

How much cash does Neogen have?

In the past 10 years, Neogen's cash and equivalents has ranged from $40.68 million in 2014 to $170.61 million in 2024, and is currently $170.61 million as of their latest financial filing in 2024.

How has Neogen's book value per share changed over the last 10 years?

Over the last 10 years, Neogen's book value per share changed from 8.36 in 2014 to 14.52 in 2024, a change of 73.7%.

Related Companies

This page (NASDAQ:NEOG) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Neogen (NEOG) Financials

Frequently Asked Questions About Neogen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Neogen (NEOG) Financials

Annual Income Statements for Neogen

Quarterly Income Statements for Neogen

Annual Cash Flow Statements for Neogen

Quarterly Cash Flow Statements for Neogen

Annual Balance Sheets for Neogen

Quarterly Balance Sheets for Neogen

Annual Metrics And Ratios for Neogen

Quarterly Metrics And Ratios for Neogen

Frequently Asked Questions About Neogen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools